60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $307 | $256 | $261 | $135 |
Gross Profit | 50 | 90 | 112 | 23 |
EBITDA | -1,604 | -1,858 | -2,032 | -2,144 |
EBIT | -1,624 | -1,875 | -2,047 | -2,158 |
Net Income | -1,716 | -1,876 | -2,045 | -2,159 |
Net Change In Cash | 307 | 256 | 261 | 135 |
Free Cash Flow | 1,602 | -1,602 | -1,640 | -1,719 |
Cash | 1,966 | 3,451 | 1,659 | 3,300 |
Basic Shares | 1,472 | 1,283 | 454 | 2,443 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $681 | $253 | $223 | $1,160 |
Gross Profit | 222 | -220 | -209 | 309 |
EBITDA | -7,883 | -1,426 | -2,109 | -1,014 |
EBIT | -7,947 | -1,526 | -2,187 | -1,086 |
Net Income | -7,947 | -3,765 | -6,181 | -4,251 |
Net Change In Cash | 681 | 253 | 223 | 1,160 |
Free Cash Flow | -5,829 | -4,658 | -1,070 | -684 |
Cash | 1,659 | 2,142 | 264 | 115 |
Basic Shares | 454 | 3,960 | 5,781 | 5,781 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.16 |
2025-03-31 | -$1.55 |
2024-12-31 | -$2.16 |
